Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2003;23:911-912
doi: 10.1161/01.ATV.0000068685.72914.7E
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cross, L. M.
Right arrow Articles by Rubinstein, A. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cross, L. M.
Right arrow Articles by Rubinstein, A. L.
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2003;23:911.)
© 2003 American Heart Association, Inc.


Letters to the Editor

Rapid Analysis of Angiogenesis Drugs in a Live Fluorescent Zebrafish Assay

Laura M. Cross; Marisa A. Cook; Shuo Lin; Jau-Nian Chen; Amy L. Rubinstein

Zygogen, LLC (L.M.C., M.A.C., S.L., A.L.R.), Atlanta, GA; and Department of Molecular, Cellular, and Developmental Biology (S.L., J.-N.C.), University of California, Los Angeles


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 

To the Editor:

Solid tumors require an adequate supply of blood vessels to survive, grow, and metastasize.1–3 New blood vessels that nourish growing tumors form by angiogenesis. Drugs shown to have anti-angiogenic activity are currently in clinical cancer trials.4 To date, anti-angiogenic drugs have had mixed success in clinical application. Many new compounds may need to be tested to identify drugs capable of treating a wide range of tumors. The ideal assay for screening new compounds should involve blood vessels growing in their natural environment, such as a whole living organism, yet be amenable to rapid analysis. No current assays provide such a unique combination. We describe here an assay using the zebrafish (Danio rerio) that provides the relevance of an in vivo environment as well as the potential for high throughput drug screening.

The zebrafish has become a well accepted model for studies of vertebrate developmental biology. The vascular system has been well described and shown to be highly conserved in the zebrafish.5,6 Many zebrafish blood vessels form by angiogenic sprouting and appear to require the same proteins that are necessary for blood vessel growth in mammals. In addition, anti-angiogenic compounds, such as PTK787/ZK222584 and SU5416, have been shown to affect the formation of zebrafish blood vessels.7,8

Current methods of visualizing blood vessels in the zebrafish include whole mount in situ hybridization,9,10 detection of endogenous alkaline phosphatase activity,8 and microangiography.11 The first two methods are time consuming and involve fixation of embryos and larvae prior to analysis. . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
BloodHome page
C. Urbinati, S. Nicoli, M. Giacca, G. David, S. Fiorentini, A. Caruso, M. Alfano, L. Cassetta, M. Presta, and M. Rusnati
HIV-1 Tat and heparan sulfate proteoglycan interaction: a novel mechanism of lymphocyte adhesion and migration across the endothelium
Blood, October 8, 2009; 114(15): 3335 - 3342.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
J. D. San Antonio, J. J. Zoeller, K. Habursky, K. Turner, W. Pimtong, M. Burrows, S. Choi, S. Basra, J. S. Bennett, W. F. DeGrado, et al.
A Key Role for the Integrin {alpha}2{beta}1 in Experimental and Developmental Angiogenesis
Am. J. Pathol., September 1, 2009; 175(3): 1338 - 1347.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. K. Garnaas, K. L. Moodie, M.-l. Liu, G. V. Samant, K. Li, R. Marx, J. M. Baraban, A. Horowitz, and R. Ramchandran
Syx, a RhoA Guanine Exchange Factor, Is Essential for Angiogenesis In Vivo
Circ. Res., September 26, 2008; 103(7): 710 - 716.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
V. Mehta, R. E. Peterson, and W. Heideman
2,3,7,8-Tetrachlorodibenzo-p-dioxin Exposure Prevents Cardiac Valve Formation in Developing Zebrafish
Toxicol. Sci., August 1, 2008; 104(2): 303 - 311.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Nicoli, C. Tobia, L. Gualandi, G. De Sena, and M. Presta
Calcitonin receptor-like receptor guides arterial differentiation in zebrafish
Blood, May 15, 2008; 111(10): 4965 - 4972.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
J.-W. Xiong, Q. Yu, J. Zhang, and J. D. Mably
An Acyltransferase Controls the Generation of Hematopoietic and Endothelial Lineages in Zebrafish
Circ. Res., May 9, 2008; 102(9): 1057 - 1064.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
J. J. Zoeller, A. McQuillan, J. Whitelock, S.-Y. Ho, and R. V. Iozzo
A central function for perlecan in skeletal muscle and cardiovascular development
J. Cell Biol., April 21, 2008; 181(2): 381 - 394.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. C. Tran, B. Sneed, J. Haider, D. Blavo, A. White, T. Aiyejorun, T. C. Baranowski, A. L. Rubinstein, T. N. Doan, R. Dingledine, et al.
Automated, Quantitative Screening Assay for Antiangiogenic Compounds Using Transgenic Zebrafish
Cancer Res., December 1, 2007; 67(23): 11386 - 11392.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Nicoli, D. Ribatti, F. Cotelli, and M. Presta
Mammalian Tumor Xenografts Induce Neovascularization in Zebrafish Embryos
Cancer Res., April 1, 2007; 67(7): 2927 - 2931.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
F. Nakazawa, H. Nagai, M. Shin, and G. Sheng
Negative regulation of primitive hematopoiesis by the FGF signaling pathway
Blood, November 15, 2006; 108(10): 3335 - 3343.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
H. Zhong, X. Wu, H. Huang, Q. Fan, Z. Zhu, and S. Lin
Vertebrate MAX-1 is required for vascular patterning in zebrafish
PNAS, November 7, 2006; 103(45): 16800 - 16805.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
X. Wu, H. Zhong, J. Song, R. Damoiseaux, Z. Yang, and S. Lin
Mycophenolic Acid Is a Potent Inhibitor of Angiogenesis
Arterioscler Thromb Vasc Biol, October 1, 2006; 26(10): 2414 - 2416.
[Full Text] [PDF]


Home page
DevelopmentHome page
X. Li, J.-W. Xiong, C. S. Shelley, H. Park, and M. A. Arnaout
The transcription factor ZBP-89 controls generation of the hematopoietic lineage in zebrafish and mouse embryonic stem cells
Development, September 15, 2006; 133(18): 3641 - 3650.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Kaur, M. D. Castellone, V. M. Bedell, M. Konar, J. S. Gutkind, and R. Ramchandran
Robo4 Signaling in Endothelial Cells Implies Attraction Guidance Mechanisms
J. Biol. Chem., April 21, 2006; 281(16): 11347 - 11356.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
S.-W. Jin, D. Beis, T. Mitchell, J.-N. Chen, and D. Y. R. Stainier
Cellular and molecular analyses of vascular tube and lumen formation in zebrafish
Development, December 1, 2005; 132(23): 5199 - 5209.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
V. M. Bedell, S.-Y. Yeo, K. W. Park, J. Chung, P. Seth, V. Shivalingappa, J. Zhao, T. Obara, V. P. Sukhatme, I. A. Drummond, et al.
roundabout4 is essential for angiogenesis in vivo
PNAS, May 3, 2005; 102(18): 6373 - 6378.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. Belleri, D. Ribatti, S. Nicoli, F. Cotelli, L. Forti, V. Vannini, L. A. Stivala, and M. Presta
Antiangiogenic and Vascular-Targeting Activity of the Microtubule-Destabilizing trans-Resveratrol Derivative 3,5,4'-Trimethoxystilbene
Mol. Pharmacol., May 1, 2005; 67(5): 1451 - 1459.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
E. B. Friedrich, E. Liu, S. Sinha, S. Cook, D. S. Milstone, C. A. MacRae, M. Mariotti, P. J. Kuhlencordt, T. Force, A. Rosenzweig, et al.
Integrin-Linked Kinase Regulates Endothelial Cell Survival and Vascular Development
Mol. Cell. Biol., September 15, 2004; 24(18): 8134 - 8144.
[Abstract] [Full Text] [PDF]